Ensuring the Quality Standards of Pharmaceutical Manufacturing Practices, to Achieve Maximum Public Safety by Exploring

OMICS Group Inc's picture
Printer-friendly versionPrinter-friendly versionPDF versionPDF version

OMICS Group cordially invite all the participants who are interested in sharing their knowledge and research in the field of Pharmacy. After a successful conference in 2013, which tracked the evolution of GMP, GCP OCM would like to invite you to participate in 3rd International Summit on GMP, GCP & Quality Control Slated on September 25-26, 2014, at Valencia Convention Center, Spain.


Valencia, Spain, Europe, December 19, 2013 - (PressReleasePoint) -
A new quality era is happening – one where the industry, healthcare and the patient demand more and we as an industry need to innovate our approach. This ongoing transformation in pharma has seen the industry strive towards a more quality to drug formulations than ever before. 
 
The Organizing committee would like to invite all the participants as a Speaker/Delegate/Exhibitor for the conference.
 
The conference offers a broad range of highly interactive sessions with case studies and lectures where experts will share their knowledge and experiences in the following areas:
 
·         Good Manufacturing Practices: The Gap within                         
·         Contract Manufacturing, Lean Manufacturing, Six Sigma Approaches
·         Current Regulations and Quality Standards                                
·         GMP in Microbiology and Biotechnology
·         The Role of "C" in cGMP, Current GMP Guidelines (cGMP)    
·         GMP in Food Industry, Medical Devices
·         Good Clinical Practices & Good Laboratory Practices               
·         Computational Strategies in GMP/GCP
·         Quality Assurance, Quality Control, Validation                         
·         Storage, Distribution, Transportation
 
The GMP Summit-2014 will also be accompanied by an industrial exhibition
Top reasons to attend:

  • Get the bigger picture with unique insights into the challenges, potential solutions and future directions of the drug safety industry
  • Gain the necessary understanding of global regulatory developments
  • Understand how to create a more patient-centric safety strategy
  • Join the debate on the biggest issues affecting the drug safety sector
  • Delve into the issues at the interface of manufacturing

 
OMICS Group International is an amalgamation of Open Access publications and worldwide international science conferences and events. Established in the year 2007 with the sole aim of making the information on Sciences and technology ‘Open Access’, OMICS Group publishes 300 online open access scholarly journals in all aspects of Science, Engineering, Management and Technology journals. OMICS Group has been instrumental in taking the knowledge on Science & technology to the doorsteps of ordinary men and women. Research Scholars, Students, Libraries, Educational Institutions, Research centers and the industry are main stakeholders that benefitted greatly from this knowledge dissemination. OMICS Group also organizes 100 International conferences annually across the globe, where knowledge transfer takes place through debates, round table discussions, poster presentations, workshops, symposia and exhibitions.Please visit to know more about the conference, PS: http://www.pharmaceuticalconferences.com/gmp-gcp-quality-control-2014/
 
Contact Details:
Victor Oliver
GMP Summit-2014
Pharma Conferences
5716 Corsa Ave, Suite110
Westlake, Los Angeles
CA-91362-7354, USA
Office Ph: +1-888-843-8169
Email gmpsummit2014@omicsgroup.us


Healthcare, California


Press Contact:
Victor Oliver

5716 Corsa Ave¦Suite110Westlake, Los AngelesCA-91362-7354, USA


8888438169
http://omicsonline.org
*******.******@**i**g**u*.net
Email partially hidden to block spam. Please use the contact form here.
Contact Victor Oliver
Email the contact person for this press release. Do not send spam or irrelevant message.
7 + 7 =


Copy this html code to your website/blog to embed this press release.